MediSpectra Inc.

MediSpectra Inc. of Lexington, Mass., has received FDA approval for the Luma cervical imaging system. When used in conjunction with colposcopy — for women who have had abnormal Pap test results — the noncontact optical imaging device is expected to improve the detection of high-grade cervical cancer precursors. A 12-s scan combines fluorescence spectroscopy, white-light diffuse reflectance spectroscopy and video imaging to provide results during the examination.





LATEST NEWS

• 3D Holography Integrated Glasses Could Unlock Mixed Reality
  May 2, 2024
• Generative AI Achieves Superresolution with Minimal Tuning
  May 2, 2024
• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024
• Machine Learning Pushes High-Power Lasing Limits
  May 1, 2024
• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024
• TSMC Partnerships Target Integrated Photonics Capabilities
  Apr 30, 2024